These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 33033523)
1. MiR-135-5p inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by targeting SMAD3 in breast cancer. Yang W; Feng W; Wu F; Gao Y; Sun Q; Hu N; Lu W; Zhou J J Cancer; 2020; 11(21):6402-6412. PubMed ID: 33033523 [TBL] [Abstract][Full Text] [Related]
2. Suppression of non-small cell lung cancer migration and invasion by hsa-miR-486-5p via the TGF-β/SMAD2 signaling pathway. Chen T; Zhu J; Cai T; Du W; Zhang Y; Zhu Q; Liu Z; Huang JA J Cancer; 2019; 10(24):6014-6024. PubMed ID: 31762811 [TBL] [Abstract][Full Text] [Related]
3. Linc00511 Knockdown Inhibited TGF-β1-Induced Epithelial-Mesenchymal Transition of Bronchial Epithelial Cells by Targeting miR-16-5p/Smad3. She W; Sun T; Long C; Chen M; Chen X; Liao Q; Wang M Am J Rhinol Allergy; 2023 May; 37(3):313-323. PubMed ID: 36594176 [TBL] [Abstract][Full Text] [Related]
4. miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherin. Yang L; Liu S; Yang L; Xu B; Wang M; Kong X; Song Z Oncol Lett; 2022 May; 23(5):162. PubMed ID: 35399330 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer. Wang S; Huang M; Wang Z; Wang W; Zhang Z; Qu S; Liu C Int J Oncol; 2019 Nov; 55(5):1097-1109. PubMed ID: 31545407 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1. Zhao C; Ling X; Li X; Hou X; Zhao D Breast Cancer; 2019 Nov; 26(6):817-825. PubMed ID: 31243644 [TBL] [Abstract][Full Text] [Related]
7. Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer. Tan X; Li Z; Ren S; Rezaei K; Pan Q; Goldstein AT; Macri CJ; Cao D; Brem RF; Fu SW Breast Cancer Res; 2019 Aug; 21(1):89. PubMed ID: 31391072 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer. Li J; Zou K; Yu L; Zhao W; Lu Y; Mao J; Wang B; Wang L; Fan S; Song B; Li L Mol Ther Nucleic Acids; 2018 Mar; 10():426-437. PubMed ID: 29499953 [TBL] [Abstract][Full Text] [Related]
9. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells. Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033 [TBL] [Abstract][Full Text] [Related]
10. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145. Xiang Y; Zhang Y; Tang Y; Li Q Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-32-5p inhibits epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting SMAD family 3. Zhang JX; Yang W; Wu JZ; Zhou C; Liu S; Shi HB; Zhou WZ J Cancer; 2021; 12(8):2258-2267. PubMed ID: 33758603 [TBL] [Abstract][Full Text] [Related]
12. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression. Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320 [TBL] [Abstract][Full Text] [Related]
13. MiR-448-5p inhibits TGF-β1-induced epithelial-mesenchymal transition and pulmonary fibrosis by targeting Six1 in asthma. Yang ZC; Qu ZH; Yi MJ; Shan YC; Ran N; Xu L; Liu XJ J Cell Physiol; 2019 Jun; 234(6):8804-8814. PubMed ID: 30362537 [TBL] [Abstract][Full Text] [Related]
14. Potential Novel Prediction of TMJ-OA: MiR-140-5p Regulates Inflammation Through Smad/TGF-β Signaling. Li W; Zhao S; Yang H; Zhang C; Kang Q; Deng J; Xu Y; Ding Y; Li S Front Pharmacol; 2019; 10():15. PubMed ID: 30728776 [TBL] [Abstract][Full Text] [Related]
15. MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer. Jiang K; Zhao T; Shen M; Zhang F; Duan S; Lei Z; Chen Y J Cancer; 2019; 10(12):2735-2744. PubMed ID: 31258781 [TBL] [Abstract][Full Text] [Related]
16. MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2. Zhu D; Gu L; Li Z; Jin W; Lu Q; Ren T Pathol Res Pract; 2019 May; 215(5):861-872. PubMed ID: 30712885 [TBL] [Abstract][Full Text] [Related]
17. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling. Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537 [No Abstract] [Full Text] [Related]
18. MicroRNA-486-5p suppresses TGF-β2-induced proliferation, invasion and epithelial-mesenchymal transition of lens epithelial cells by targeting Smad2. Liu B; Sun J; Lei X; Zhu Z; Pei C; Qin L J Biosci; 2017 Dec; 42(4):575-584. PubMed ID: 29229876 [TBL] [Abstract][Full Text] [Related]
19. miR-335-5p inhibits TGF-β1-induced epithelial-mesenchymal transition in non-small cell lung cancer via ROCK1. Du W; Tang H; Lei Z; Zhu J; Zeng Y; Liu Z; Huang JA Respir Res; 2019 Oct; 20(1):225. PubMed ID: 31638991 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer. Huo W; Zhu XM; Pan XY; Du M; Sun Z; Li ZM Math Biosci Eng; 2019 May; 16(5):4607-4621. PubMed ID: 31499680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]